tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA

Enanta Pharmaceuticals (ENTA) Ownership - Who Owns Enanta Pharmaceuticals?

151 Followers

Enanta Pharmaceuticals (ENTA) Ownership Overview

37.36%17.57%12.77%32.30%
37.36% Insiders
12.77% Other Institutional Investors
32.30% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail and individual investors. Approximately 30.34% of the company’s stock is owned by Institutional Investors, 37.36% is owned by Insiders and 32.30% is owned by Public Companies and Individual Investors.
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail and individual investors. Approximately 30.34% of the company’s stock is owned by Institutional Investors, 37.36% is owned by Insiders and 32.30% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 27, 2024Bought$46631
Dec 15, 2023
Terry Vance
Director
Sold$139490
Dec 06, 2023Sold$23228
Dec 06, 2023Sold$20464

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$125717
Dec 31, 2023Bought$19055250

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,025,000Institution9.57%26,628,750
1,068,386Institution5.05%14,049,276
872,169Institution4.12%11,469,022
810,609Insider3.83%10,659,508
722,754Institution3.42%9,504,215
411,659Institution1.95%5,413,316
373,295Insider1.76%4,908,829
216,946Institution1.03%2,852,840
212,086Institution1.00%2,788,931
191,361Institution0.90%2,516,397

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
872,169Institution4.12%11,469,022
411,659Institution1.95%5,413,316
216,946Institution1.03%2,852,840
212,086Institution1.00%2,788,931
191,361Institution0.90%2,516,397
172,358Institution0.81%2,266,508
166,553Institution0.79%2,190,172
137,615Institution0.65%1,809,637
118,106Institution0.56%1,553,094
115,421Institution0.55%1,517,786

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
629,597Institution2.98%10,992,764
489,231Institution2.31%6,433,388
280,040Institution1.32%4,889,498
167,997Institution0.79%2,209,161
75,661Institution0.36%1,321,041
95,674Institution0.45%1,258,113
67,586Institution0.32%1,180,052
36,202Institution0.17%940,890
43,695Institution0.21%574,589
39,256Institution0.19%516,216

FAQ

Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 12.77% of the company's stock is held by institutional investors, 37.36% is held by insiders, and 32.30% is held by retail investors.
    What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 12.77% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
      What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 32.30% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
        Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
        Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis